Aktieanalys

Lipum: Approval To Initiate Phase I Trial - Redeye

{newsItem.title}

Redeye Publicerad: 28 Sep 2022 07:48

Redeye leaves a short comment on Lipum’s announcement of a CTA approval for the phase I trial with SOL-116.

Länk till analysen i sin helhet: https://www.redeye.se/research/856467/lipum-approval-to-initiate-phase-i-trial?utm_source=finwire&utm_medium=RSS

Nyheter om Lipum

Läses av andra just nu

Om aktien Lipum

Senaste nytt